154 related articles for article (PubMed ID: 3948152)
21. Energy-dependent efflux of methotrexate in L1210 leukemia cells. Evidence for the role of an ATPase obtained with inside-out plasma membrane vesicles.
Schlemmer SR; Sirotnak FM
J Biol Chem; 1992 Jul; 267(21):14746-52. PubMed ID: 1386081
[TBL] [Abstract][Full Text] [Related]
22. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
[TBL] [Abstract][Full Text] [Related]
23. Identification of efflux systems for large anions and anionic conjugates as the mediators of methotrexate efflux in L1210 Cells.
Saxena M; Henderson GB
Biochem Pharmacol; 1996 Apr; 51(7):974-82. PubMed ID: 8651948
[TBL] [Abstract][Full Text] [Related]
24. Mediation of cellular anion detoxification in leukemic cells by unidirectional efflux pumps.
Henderson GB
Adv Enzyme Regul; 1989; 29():61-72. PubMed ID: 2561249
[TBL] [Abstract][Full Text] [Related]
25. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
Sierra EE; Goldman ID
Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
[TBL] [Abstract][Full Text] [Related]
26. Properties of an anion/H+ cotransport system in L1210 cells that utilizes phthalate as a nonphysiological substrate.
Henderson GB; Zevely EM
J Membr Biol; 1986; 89(1):99-106. PubMed ID: 3959065
[TBL] [Abstract][Full Text] [Related]
27. Structural requirements for anion substrates of the methotrexate transport system in L1210 cells.
Henderson GB; Zevely EM
Arch Biochem Biophys; 1983 Mar; 221(2):438-46. PubMed ID: 6838199
[TBL] [Abstract][Full Text] [Related]
28. Role of N-glycosylation in the structure and function of the methotrexate membrane transporter from CCRF-CEM human lymphoblastic leukemia cells.
Matherly LH; Angeles SM
Biochem Pharmacol; 1994 Mar; 47(6):1094-8. PubMed ID: 8147910
[TBL] [Abstract][Full Text] [Related]
29. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
[TBL] [Abstract][Full Text] [Related]
30. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux.
Sirotnak FM; Moccio DM; Young CW
Cancer Res; 1981 Mar; 41(3):966-70. PubMed ID: 7459883
[TBL] [Abstract][Full Text] [Related]
31. Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling, and identification of the membrane carrier protein for methotrexate from murine L1210 cells.
Price EM; Freisheim JH
Biochemistry; 1987 Jul; 26(15):4757-63. PubMed ID: 3663624
[TBL] [Abstract][Full Text] [Related]
32. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines.
Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G
Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203
[TBL] [Abstract][Full Text] [Related]
33. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
Yang CH; Sirotnak FM; Mines LS
J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
[TBL] [Abstract][Full Text] [Related]
34. The transport of pteridines in CCRF-CEM human lymphoblastic cells.
Webber S; Nazarbaghi R
Cancer Chemother Pharmacol; 1989; 23(5):283-90. PubMed ID: 2706732
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
Henderson GB; Strauss BP
Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
Sirotnak FM; Poser RE; Barrueco JR
Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
[TBL] [Abstract][Full Text] [Related]
37. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles.
Yang CH; Dembo M; Sirotnak FM
J Membr Biol; 1983; 75(1):11-20. PubMed ID: 6887234
[TBL] [Abstract][Full Text] [Related]
38. Characterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors.
Matherly LH; Angeles SM; Czajkowski CA
J Biol Chem; 1992 Nov; 267(32):23253-60. PubMed ID: 1429671
[TBL] [Abstract][Full Text] [Related]
39. Membrane protein changes in an L1210 leukemia cell line with a translocation defect in the methotrexate-tetrahydrofolate cofactor transport carrier.
Schuetz JD; Westin EH; Matherly LH; Pincus R; Swerdlow PS; Goldman ID
J Biol Chem; 1989 Sep; 264(27):16261-7. PubMed ID: 2777791
[TBL] [Abstract][Full Text] [Related]
40. Affinity labeling of the 5-methyltetrahydrofolate/methotrexate transport protein of L1210 cells by treatment with an N-hydroxysuccinimide ester of [3H]methotrexate.
Henderson GB; Zevely EM
J Biol Chem; 1984 Apr; 259(7):4558-62. PubMed ID: 6707019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
